99 related articles for article (PubMed ID: 26921541)
1. The Application of Molecular Diagnostics to Stained Cytology Smears.
Oktay MH; Adler E; Hakima L; Grunblatt E; Pieri E; Seymour A; Khader S; Cajigas A; Suhrland M; Goswami S
J Mol Diagn; 2016 May; 18(3):407-415. PubMed ID: 26921541
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
[TBL] [Abstract][Full Text] [Related]
3. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
[TBL] [Abstract][Full Text] [Related]
4. The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma.
Betz BL; Roh MH; Weigelin HC; Placido JB; Schmidt LA; Farmen S; Arenberg DA; Kalemkerian GP; Knoepp SM
Am J Clin Pathol; 2011 Oct; 136(4):564-71. PubMed ID: 21917678
[TBL] [Abstract][Full Text] [Related]
5. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
6. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
Gailey MP; Stence AA; Jensen CS; Ma D
Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
[TBL] [Abstract][Full Text] [Related]
7. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
Betz BL; Dixon CA; Weigelin HC; Knoepp SM; Roh MH
Cancer Cytopathol; 2013 Sep; 121(9):489-99. PubMed ID: 23536384
[TBL] [Abstract][Full Text] [Related]
8. Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.
Lozano MD; Echeveste JI; Abengozar M; Mejías LD; Idoate MA; Calvo A; de Andrea CE
Arch Pathol Lab Med; 2018 Mar; 142(3):291-298. PubMed ID: 29494220
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.
Brachtel EF; Operaña TN; Sullivan PS; Kerr SE; Cherkis KA; Schroeder BE; Dry SM; Schnabel CA
Oncotarget; 2016 May; 7(19):27220-31. PubMed ID: 27034010
[TBL] [Abstract][Full Text] [Related]
10. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
11. Detection of SYT-SSX mutant transcripts in formalin-fixed paraffin-embedded sarcoma tissues using one-step reverse transcriptase real-time PCR.
Norlelawati AT; Mohd Danial G; Nora H; Nadia O; Zatur Rawihah K; Nor Zamzila A; Naznin M
Malays J Pathol; 2016 Apr; 38(1):11-8. PubMed ID: 27126659
[TBL] [Abstract][Full Text] [Related]
12. Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma.
Hookim K; Roh MH; Willman J; Placido J; Weigelin HC; Fields KL; Pang J; Betz BL; Knoepp SM
Cancer Cytopathol; 2012 Feb; 120(1):52-61. PubMed ID: 21793228
[TBL] [Abstract][Full Text] [Related]
13. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
Kwon HJ; Kim EK; Kwak JY
Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
[TBL] [Abstract][Full Text] [Related]
14. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
[TBL] [Abstract][Full Text] [Related]
15. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.
Borrelli N; Ugolini C; Giannini R; Antonelli A; Giordano M; Sensi E; Torregrossa L; Fallahi P; Miccoli P; Basolo F
Cancer Cytopathol; 2016 May; 124(5):340-9. PubMed ID: 26749005
[TBL] [Abstract][Full Text] [Related]
16. Reverse transcription-polymerase chain reaction molecular testing of cytology specimens: Pre-analytic and analytic factors.
Bridge JA
Cancer Cytopathol; 2017 Jan; 125(1):11-19. PubMed ID: 27412734
[TBL] [Abstract][Full Text] [Related]
17. Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.
Harada S; Agosto-Arroyo E; Levesque JA; Alston E; Janowski KM; Coshatt GM; Eltoum IA
Cancer Cytopathol; 2015 Aug; 123(8):480-7. PubMed ID: 25955105
[TBL] [Abstract][Full Text] [Related]
18. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
19. Applications and limitations of oncogene mutation testing in clinical cytopathology.
Bellevicine C; Vita GD; Malapelle U; Troncone G
Semin Diagn Pathol; 2013 Nov; 30(4):284-97. PubMed ID: 24342285
[TBL] [Abstract][Full Text] [Related]
20. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
